Shopping Cart
- Remove All
- Your shopping cart is currently empty
Triacsin C (WS 1228A) from Streptomyces aureofaciens is a differential inhibitor of arachidonic acid coenzyme A synthetase and non-specific long-chain acyl-coenzyme A synthetase, with anti-atherosclerotic activity, inhibition of ACSL activity, and inhibition of the accumulation of TAGs into lipid droplets (LDs).Triacsin C has been used to study rotavirus infection and Alzheimer;s disease. Triacsin C is used to study rotavirus infection and Alzheimer;s disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
500 μg | Inquiry | 35 days | |
1 mg | Inquiry | 35 days |
Description | Triacsin C (WS 1228A) from Streptomyces aureofaciens is a differential inhibitor of arachidonic acid coenzyme A synthetase and non-specific long-chain acyl-coenzyme A synthetase, with anti-atherosclerotic activity, inhibition of ACSL activity, and inhibition of the accumulation of TAGs into lipid droplets (LDs).Triacsin C has been used to study rotavirus infection and Alzheimer;s disease. Triacsin C is used to study rotavirus infection and Alzheimer;s disease. |
Targets&IC50 | CpACS1:3.70 μM, CpACS2:2.32 μM |
In vivo | In interleukin knockout mice infected with Cryptosporidium, Triacsin C (8-15 mg/kg/d; oral gavage; 1 week) reduced parasite oocyst production by up to 88.1% with no apparent toxicity[3]. |
Alias | WS 1228A, FR 900190 |
Molecular Weight | 207.27 |
Formula | C11H17N3O |
Cas No. | 76896-80-5 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
Solubility Information | DMSO: 2 mg/mL (9.65 mM), Sonication is recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.